Engene to present at the jefferies global healthcare conference

Boston & montreal--(business wire)--engene holdings inc. (nasdaq: engn or “engene” or the “company”), a clinical-stage, non-viral genetic medicines company, today announced that ron cooper, chief executive officer, will present at the jefferies global healthcare conference in new york city on wednesday, june 4, 2025, at 11:05 a.m. et. a live webcast of the presentation can be accessed under the “investors” section of the engene website at www.engene.com and will be archived there for 90 days. a.
ENGN Ratings Summary
ENGN Quant Ranking